Investors Purchase High Volume of CME Group Call Options (NASDAQ:CME)

CME Group Inc. (NASDAQ:CME) saw unusually large options trading on Wednesday. Traders purchased 8,099 call options on the stock. This is an increase of approximately 129% compared to the average daily volume of 3,537 call options.

Wall Street Analyst Weigh In

A number of research firms have commented on CME. Morgan Stanley decreased their target price on shares of CME Group from $353.00 to $324.00 and set an “overweight” rating on the stock in a research report on Friday, July 10th. UBS Group dropped their price target on shares of CME Group from $310.00 to $260.00 and set a “buy” rating for the company in a research report on Monday, July 6th. JPMorgan Chase & Co. boosted their price target on shares of CME Group from $266.00 to $271.00 and gave the company an “underweight” rating in a research note on Thursday, April 16th. Weiss Ratings lowered shares of CME Group from a “buy (b)” rating to a “buy (b-)” rating in a report on Monday, July 13th. Finally, Jefferies Financial Group lowered their price objective on shares of CME Group from $356.00 to $349.00 and set a “buy” rating for the company in a research report on Thursday, April 9th. Twelve analysts have rated the stock with a Buy rating, four have issued a Hold rating and two have given a Sell rating to the company’s stock. According to data from MarketBeat.com, CME Group has an average rating of “Moderate Buy” and an average price target of $292.12.

CME Group News Summary

Here are the key news stories impacting CME Group this week:

• Positive Sentiment: CME Group posted Q2 adjusted earnings of $2.99 per share, topping estimates, while revenue of about $1.71 billion also beat forecasts. The upside was supported by strong hedging demand and active derivatives trading, which reinforced confidence in the company’s core exchange business. Reuters article
• Positive Sentiment: Management said the first half of 2026 was the strongest in company history for revenue, adjusted operating income, adjusted net income, and adjusted diluted EPS, suggesting momentum remains solid heading into the rest of the year. Quiver Quantitative article
• Positive Sentiment: Trading volumes were strong, with average daily volume near 29.8 million contracts and record market data revenue of $238 million, both of which support the view that CME is benefiting from elevated market activity and pricing power. Seeking Alpha presentation
• Positive Sentiment: Shares also gained support from unusual call-option buying and broader investor interest following the earnings beat, which can reinforce near-term upward momentum. Quiver Quantitative options flow article
• Neutral Sentiment: CEO Terrence Duffy pushed back on market chatter about potential perpetual-futures products, saying clients are not demanding them. That appears to have been a side issue rather than a direct driver of the move. Bloomberg article

Insider Buying and Selling at CME Group

In other news, insider Hilda Harris Piell sold 5,753 shares of the stock in a transaction on Monday, May 18th. The stock was sold at an average price of $304.63, for a total transaction of $1,752,536.39. Following the completion of the transaction, the insider directly owned 27,702 shares in the company, valued at approximately $8,438,860.26. This represents a 17.20% decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, Director William R. Shepard acquired 325 shares of the business’s stock in a transaction that occurred on Thursday, June 25th. The shares were acquired at an average cost of $230.57 per share, with a total value of $74,935.25. Following the completion of the transaction, the director directly owned 260,442 shares in the company, valued at approximately $60,050,111.94. The trade was a 0.12% increase in their position. The SEC filing for this purchase provides additional information. Company insiders own 0.30% of the company’s stock.

Hedge Funds Weigh In On CME Group

Several large investors have recently bought and sold shares of CME. Rehmann Capital Advisory Group increased its stake in shares of CME Group by 4.3% during the 3rd quarter. Rehmann Capital Advisory Group now owns 898 shares of the financial services provider’s stock valued at $243,000 after acquiring an additional 37 shares during the last quarter. Asset Dedication LLC lifted its holdings in shares of CME Group by 64.9% during the 4th quarter. Asset Dedication LLC now owns 94 shares of the financial services provider’s stock worth $26,000 after acquiring an additional 37 shares during the period. Northwestern Mutual Investment Management Company LLC boosted its position in shares of CME Group by 0.3% in the fourth quarter. Northwestern Mutual Investment Management Company LLC now owns 11,523 shares of the financial services provider’s stock worth $3,147,000 after acquiring an additional 37 shares during the last quarter. Sovran Advisors LLC boosted its position in shares of CME Group by 3.5% in the fourth quarter. Sovran Advisors LLC now owns 1,118 shares of the financial services provider’s stock worth $305,000 after acquiring an additional 38 shares during the last quarter. Finally, Endowment Wealth Management Inc. grew its holdings in CME Group by 4.4% in the fourth quarter. Endowment Wealth Management Inc. now owns 895 shares of the financial services provider’s stock valued at $244,000 after purchasing an additional 38 shares during the period. Hedge funds and other institutional investors own 87.75% of the company’s stock.

CME Group Stock Up 5.0%

Shares of NASDAQ:CME opened at $249.24 on Thursday. CME Group has a fifty-two week low of $218.31 and a fifty-two week high of $329.16. The firm’s 50 day moving average price is $255.87 and its 200 day moving average price is $281.51. The company has a quick ratio of 1.02, a current ratio of 1.02 and a debt-to-equity ratio of 0.13. The stock has a market cap of $90.31 billion, a price-to-earnings ratio of 21.27, a price-to-earnings-growth ratio of 2.95 and a beta of 0.25.

CME Group (NASDAQ:CME) last posted its quarterly earnings results on Wednesday, July 22nd. The financial services provider reported $2.99 EPS for the quarter, topping the consensus estimate of $2.91 by $0.08. CME Group had a net margin of 63.19% and a return on equity of 15.42%. The company had revenue of $1.71 billion during the quarter, compared to analysts’ expectations of $1.68 billion. During the same quarter in the previous year, the business posted $2.96 EPS. The firm’s revenue was up .8% on a year-over-year basis. As a group, equities research analysts predict that CME Group will post 12.17 earnings per share for the current fiscal year.

CME Group Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Thursday, June 25th. Stockholders of record on Tuesday, June 9th were given a dividend of $1.30 per share. This represents a $5.20 annualized dividend and a dividend yield of 2.1%. The ex-dividend date of this dividend was Tuesday, June 9th. CME Group’s payout ratio is 44.37%.

About CME Group

CME Group Inc is a global markets company that operates some of the world’s largest and most liquid derivatives exchanges, including the Chicago Mercantile Exchange (CME), the Chicago Board of Trade (CBOT), the New York Mercantile Exchange (NYMEX) and COMEX. The firm offers futures and options contracts across a broad range of asset classes — including interest rates, equity indexes, foreign exchange, energy, agricultural commodities and metals — and serves a diverse client base of institutional investors, commercial hedgers, brokers and retail participants.

The company’s core services include electronic trading on the CME Globex platform, central clearing through CME Clearing, and distribution of market data, indexes and analytics.